Van den Eynde B - Search Results

1

C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients.

Tykodi SS, Fujii N, Vigneron N, Lu SM, Mito JK, Miranda MX, Chou J, Voong LN, Thompson JA, Sandmaier BM, Cresswell P, Van den Eynde B, Riddell SR, Warren EH. Tykodi SS, et al. Among authors: van den eynde b. Clin Cancer Res. 2008 Aug 15;14(16):5260-9. doi: 10.1158/1078-0432.CCR-08-0028. Clin Cancer Res. 2008. PMID: 18698046 Free PMC article.

2

Presence on a human melanoma of multiple antigens recognized by autologous CTL.

Van den Eynde B, Hainaut P, Hérin M, Knuth A, Lemoine C, Weynants P, van der Bruggen P, Fauchet R, Boon T. Van den Eynde B, et al. Among authors: van der bruggen p. Int J Cancer. 1989 Oct 15;44(4):634-40. doi: 10.1002/ijc.2910440413. Int J Cancer. 1989. PMID: 2529220

3

A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma.

Brändle D, Brasseur F, Weynants P, Boon T, Van den Eynde B. Brändle D, et al. Among authors: van den eynde b. J Exp Med. 1996 Jun 1;183(6):2501-8. doi: 10.1084/jem.183.6.2501. J Exp Med. 1996. PMID: 8676070 Free PMC article.

4

Tumor antigens recognized by T lymphocytes.

Van den Eynde BJ, Boon T. Van den Eynde BJ, et al. Int J Clin Lab Res. 1997;27(2):81-6. doi: 10.1007/BF02912440. Int J Clin Lab Res. 1997. PMID: 9266277 Review.

5

Identification of a new peptide recognized by autologous cytolytic T lymphocytes on a human melanoma.

Vigneron N, Ooms A, Morel S, Degiovanni G, Van Den Eynde BJ. Vigneron N, et al. Cancer Immun. 2002 Jul 19;2:9. Cancer Immun. 2002. PMID: 12747754

6

Two new tumor-specific antigenic peptides encoded by gene MAGE-C2 and presented to cytolytic T lymphocytes by HLA-A2.

Ma W, Germeau C, Vigneron N, Maernoudt AS, Morel S, Boon T, Coulie PG, Van den Eynde BJ. Ma W, et al. Int J Cancer. 2004 May 1;109(5):698-702. doi: 10.1002/ijc.20038. Int J Cancer. 2004. PMID: 14999777

7

An antigenic peptide produced by peptide splicing in the proteasome.

Vigneron N, Stroobant V, Chapiro J, Ooms A, Degiovanni G, Morel S, van der Bruggen P, Boon T, Van den Eynde BJ. Vigneron N, et al. Science. 2004 Apr 23;304(5670):587-90. doi: 10.1126/science.1095522. Epub 2004 Mar 4. Science. 2004. PMID: 15001714

8

A peptide derived from melanocytic protein gp100 and presented by HLA-B35 is recognized by autologous cytolytic T lymphocytes on melanoma cells.

Vigneron N, Ooms A, Morel S, Ma W, Degiovanni G, Van den Eynde BJ. Vigneron N, et al. Among authors: van den eynde bj. Tissue Antigens. 2005 Feb;65(2):156-62. doi: 10.1111/j.1399-0039.2005.00365.x. Tissue Antigens. 2005. PMID: 15713214

9

Processing of tumor-associated antigen by the proteasomes of dendritic cells controls in vivo T-cell responses.

Chapatte L, Ayyoub M, Morel S, Peitrequin AL, Lévy N, Servis C, Van den Eynde BJ, Valmori D, Lévy F. Chapatte L, et al. Cancer Res. 2006 May 15;66(10):5461-8. doi: 10.1158/0008-5472.CAN-05-4310. Cancer Res. 2006. PMID: 16707475

10

An antigen produced by splicing of noncontiguous peptides in the reverse order.

Warren EH, Vigneron NJ, Gavin MA, Coulie PG, Stroobant V, Dalet A, Tykodi SS, Xuereb SM, Mito JK, Riddell SR, Van den Eynde BJ. Warren EH, et al. Science. 2006 Sep 8;313(5792):1444-7. doi: 10.1126/science.1130660. Science. 2006. PMID: 16960008

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

189 results

Search Page

Filters